Guangdong Jiaying Pharmaceutical Hits Day High with 7.71% Surge

Guangdong Jiaying Pharmaceutical Co., Ltd. has shown significant activity today, with the stock rising by 7.71% as of March 24, 2026. The stock reached an intraday high of CNY 7.60, marking a notable performance against the backdrop of the China Shanghai Composite, which increased by 1.78% on the same day. In terms of performance metrics, Guangdong Jiaying has experienced a mixed trajectory over various time frames. While the stock has gained 7.25% year-to-date, it has underperformed the benchmark index over the past three years, with a return of -3.71% in the last year. The company's market capitalization stands at CNY 3,313 million, categorizing it as a small-cap entity within the pharmaceuticals and biotechnology sector. Despite the recent uptick, the company faces challenges with a low Return on Capital Employed (ROCE) of 6.47% and a Price to Book ratio of 4.67, indicating a relatively expensive valuation. However, recent quarterly results have shown impressive growth in pre-tax and net profits, suggesting some positive momentum in its financial performance.